The article offers information on the prevalence and utility of inflammatory bowel disease (IBD) immune markers in Colon Ischemia. Topics discussed include reporting of immune marker seropositivity in recurrent or chronic disease, issue of autoimmune pathogenesis, and determine prognosis of Ischemic colitis (IC).